These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis. Chamling B, Bietenbeck M, Drakos S, Korthals D, Vehof V, Stalling P, Meier C, Yilmaz A. Sci Rep; 2022 Dec 16; 12(1):21755. PubMed ID: 36526658 [Abstract] [Full Text] [Related]
17. Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities. Orini M, Graham AJ, Martinez-Naharro A, Andrews CM, de Marvao A, Statton B, Cook SA, O'Regan DP, Hawkins PN, Rudy Y, Fontana M, Lambiase PD. J Am Heart Assoc; 2019 Sep 17; 8(18):e012097. PubMed ID: 31496332 [Abstract] [Full Text] [Related]
19. Z-score mapping for standardized analysis and reporting of cardiovascular magnetic resonance modified Look-Locker inversion recovery (MOLLI) T1 data: Normal behavior and validation in patients with amyloidosis. Kranzusch R, Aus dem Siepen F, Wiesemann S, Zange L, Jeuthe S, Ferreira da Silva T, Kuehne T, Pieske B, Tillmanns C, Friedrich MG, Schulz-Menger J, Messroghli DR. J Cardiovasc Magn Reson; 2020 Jan 20; 22(1):6. PubMed ID: 31955712 [Abstract] [Full Text] [Related]